BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 366142)

  • 1. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia.
    Sany J
    J Rheumatol Suppl; 1978; 4():43-7. PubMed ID: 366142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis.
    El-Ghobarey AF; Mavrikakis ME; Macleod M; Reynolds PM; Capell HA; Spencer DG; Balint G; Mathieu JP; McAllister T; Cooney A; Dick WC
    Q J Med; 1978 Jul; 47(187):385-400. PubMed ID: 102008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results.
    Feldmann JL; Mery C; Amor B; Kahan A; de Gery A; Delbarre F
    Scand J Rheumatol; 1981; 10(1):1-8. PubMed ID: 7013056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are inflammation parameters true signs of activity? A contribution to the problem of process activity and progression in chronic polyarthritis].
    Chlud K
    Z Rheumatol; 1985; 44(1):14-9. PubMed ID: 2580400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma ESR: an erythrocyte sedimentation rate adjusted for the hematocrit and hemoglobin concentration.
    Pawlotsky Y; Goasguen J; Guggenbuhl P; Veillard E; Jard C; Pouchard M; Perdriger A; Meadeb J; Chalès G
    Am J Clin Pathol; 2004 Nov; 122(5):802-10. PubMed ID: 15491977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
    Lund B; Graae A; Sonne I; Andersen RB
    Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rheumatoid arthritis with levamisole. A controlled trial.
    Runge LA; Pinals RS; Lourie SH; Tomar RH
    Arthritis Rheum; 1977; 20(8):1445-8. PubMed ID: 336052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
    Laurent MR; Panayi GS
    Agents Actions Suppl; 1980; 7():310-7. PubMed ID: 7018201
    [No Abstract]   [Full Text] [Related]  

  • 12. International symposium on levamisole in rheumatoid arthritis. A review of short and longterm effects on articular manifestations.
    Basch CM; Spitler LE; Engleman EP
    J Rheumatol Suppl; 1978; 4():11-6. PubMed ID: 366136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Maddock J; Rees P; Holly F; Aylward M
    Curr Med Res Opin; 1975; 3(5):286-97. PubMed ID: 241598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
    Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
    J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 17. Anemia and renal function in patients with rheumatoid arthritis.
    Wolfe F; Michaud K
    J Rheumatol; 2006 Aug; 33(8):1516-22. PubMed ID: 16881108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate.
    McConkey B; Amos RS; Billingham ME; Constable TJ; Crockson RA; Crockson AP; Forster PJ
    Ann Rheum Dis; 1980 Feb; 39(1):18-21. PubMed ID: 6990881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.
    McConkey B; Crockson RA; Crockson AP
    Q J Med; 1972 Apr; 41(162):115-25. PubMed ID: 4561431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.